Showing results (221-230 of 396) with videos related to
Sort By:
Pageof 40
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1994
[Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society]G Maschmeyer, H Link, W Hiddemann, et al.Klinische Padiatrie|May 1, 1985
[DNA aneuploidy in children with acute leukemia: I. Incidence and clinical significance within the scope of the BFM studies]W Hiddemann, J Ritter, B Wörmann, et al.Cancer|May 1, 1994
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter studyG Maschmeyer, H Link, W Hiddemann, et al.Seminars in Oncology|April 1, 1992
Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase II studyW Hiddemann, C Ruelfs, C Ottensmeier, et al.British Journal of Haematology|November 11, 1999
Analysis of progenitor cell involvement in B-CLL by simultaneous immunophenotypic and genotypic analysis at the single cell levelB Gahn, B Wendenburg, C Troff, et al.Leukemia|June 1, 1995
Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivativeE Schleyer, J Braess, B Ramsauer, et al.Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|January 1, 1997
[Brief interdisciplinary oncology: a model for ambulatory, multimodal treatment of tumor patients]T Liersch, B Wörmann, H F Rauschecker, et al.The International Journal of Biological Markers|October 1, 1994
Expression of the tumor-associated glycoproteins MCA, CA 125 and BW 495/36-P in epithelial tumors of the kidney and the urinary bladderA Ammon, M H Weber, I Wallner, et al.Chemotherapy|July 8, 1999
European Surveillance of Infections in Cancer Patients--ESICM Karthaus, D Buchheidt, W Hiddemann, et al.British Journal of Haematology|June 10, 2000
Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabineJ Braess, C Wegendt, G Jahns-Streubel, et al.Pageof 40